Yang C - Search Results

1

Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration.

Zhang Y, Yang C, Zhang M, Liu H, Gong C, Zhang J, Xu S, Zou J, Kai Y, Li Y. Zhang Y, et al. Among authors: yang c. Oncotarget. 2017 Nov 18;8(64):107477-107491. doi: 10.18632/oncotarget.22491. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296180 Free PMC article.

2

Embigin, regulated by HOXC8, plays a suppressive role in breast tumorigenesis.

Chao F, Zhang J, Zhang Y, Liu H, Yang C, Wang J, Guo Y, Wen X, Zhang K, Huang B, Liu D, Li Y. Chao F, et al. Among authors: yang c. Oncotarget. 2015 Sep 15;6(27):23496-509. doi: 10.18632/oncotarget.4360. Oncotarget. 2015. PMID: 26090721 Free PMC article.

3

HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFβ1 in non-small cell lung cancer.

Liu H, Zhang M, Xu S, Zhang J, Zou J, Yang C, Zhang Y, Gong C, Kai Y, Li Y. Liu H, et al. Among authors: yang c. Oncogenesis. 2018 Jan 17;7(2):1. doi: 10.1038/s41389-017-0016-4. Oncogenesis. 2018. PMID: 29367650 Free PMC article.

4

ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin signaling pathway.

Li LY, Yang CC, Yang JF, Li HD, Zhang BY, Zhou H, Hu S, Wang K, Huang C, Meng XM, Zhou H, Zhang L, Li J, Xu T. Li LY, et al. Among authors: yang cc, yang jf. Eur J Pharmacol. 2019 Dec 15;865:172787. doi: 10.1016/j.ejphar.2019.172787. Epub 2019 Nov 8. Eur J Pharmacol. 2019. PMID: 31712061

5

The Role of IL-35 in the Pathophysiological Processes of Liver Disease.

Hu S, Lian PP, Hu Y, Zhu XY, Jiang SW, Ma Q, Li LY, Yang JF, Yang L, Guo HY, Zhou H, Yang CC, Meng XM, Li J, Li HW, Xu T, Zhou H. Hu S, et al. Front Pharmacol. 2021 Jan 21;11:569575. doi: 10.3389/fphar.2020.569575. eCollection 2020. Front Pharmacol. 2021. PMID: 33584256 Free PMC article. Review.

6

Honokiol Inhibits the Inflammatory Response and Lipid Metabolism Disorder by Inhibiting p38α in Alcoholic Liver Disease.

Yang C, Zhao Y, Luo Z, Hu Y, Wang S, Hu S, Yao Y, Pan L, Shen C, Xu T. Yang C, et al. Planta Med. 2023 Mar;89(3):273-285. doi: 10.1055/a-1878-3991. Epub 2022 Jun 17. Planta Med. 2023. PMID: 35714651

7

Corrigendum to "ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin pathway" [Eur. J. Pharmacol. 865 (2019) 172787].

Li LY, Yang CC, Yang JF, Li HD, Zhang BY, Zhou H, Hu S, Wang K, Huang C, Meng XM, Zhou H, Zhang L, Li J, Xu T. Li LY, et al. Among authors: yang cc, yang jf. Eur J Pharmacol. 2020 Feb 15;869:172848. doi: 10.1016/j.ejphar.2019.172848. Epub 2019 Dec 13. Eur J Pharmacol. 2020. PMID: 31843196 No abstract available.

8

Emerging role of RNF2 in cancer: From bench to bedside.

Yan Q, Chen BJ, Hu S, Qi SL, Li LY, Yang JF, Zhou H, Yang CC, Chen LJ, Du J. Yan Q, et al. J Cell Physiol. 2021 Aug;236(8):5453-5465. doi: 10.1002/jcp.30260. Epub 2021 Jan 5. J Cell Physiol. 2021. PMID: 33400276 Review.

9

P38γ modulates the lipid metabolism in non-alcoholic fatty liver disease by regulating the JAK-STAT signaling pathway.

Yao Y, Luo ZP, Li HW, Wang SX, Wu YC, Hu Y, Hu S, Yang CC, Yang JF, Wang JP, Peng L, Chen F, Pan LX, Xu T. Yao Y, et al. FASEB J. 2023 Jan;37(1):e22716. doi: 10.1096/fj.202200939RR. FASEB J. 2023. PMID: 36527390

10

MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88.

Xu T, Pan L, Li L, Hu S, Zhou H, Yang C, Yang J, Li H, Liu Y, Meng X, Li J. Xu T, et al. Among authors: yang c, yang j. J Cell Mol Med. 2020 Jul;24(13):7127-7140. doi: 10.1111/jcmm.15119. Epub 2020 May 28. J Cell Mol Med. 2020. PMID: 32463570 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,126 results

Search Page

Filters